Edit |   |
Antigenic Specificity | Phospho-BCL9L (Ser21) |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human, mouse, ratpredicted: porcine, zebrafish, bovine, horse, rabbit, dog |
Isotype | n/a |
Format | peptide affinity purified |
Size | 0.05 mL, 0.1 mL, 0.2 mL |
Concentration | 1mg/ml |
Applications | Western Blot (WB), Immunohistochemistry (IHC), Peptide ELISA (EIA) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Specificity: Phospho-BCL9L (Ser21) Antibody detects endogenous levels of BCL9L only when phosphorylated at Ser21. Description: Transcriptional regulator that acts as an activator. Promotes beta-catenin transcriptional activity. Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1 (By similarity).Subunit Structure: Found in a complex with CDC73; CTNNB1 and PYGO1. Interacts with CTNNB1.Similarity: Tne C-terminal domain is important for its transactivation activity. Belongs to the BCL9 family. |
Immunogen | Immunogen: A synthesized peptide derived from human BCL9L around the phosphorylation site of Ser21. Tissue Specificity: Expressed in breast, ductal and invasive ductal carcinomas of the breast, sporadic colorectal adenomas and carcinomas (at protein level). Expressed in fetal brain. Expressed in lung, amygdala, eye, prostate, pancreatic and prostate cancers, head and neck tumors and embryonal tumor. |
Other Names | [B-cell CLL; B-cell CLL/lymphoma 9-like protein; B-cell lymphoma 9-like protein; B9L; BCL9-2; BCL9-like protein; BCL9-related beta-catenin-binding protein; Bcl9l; BCL9L_HUMAN; DLNB11; Nuclear co factor of beta catenin signalling; Protein BCL9-2] |
Gene, Accession # | [BCL9L], Gene ID: 283149, NCBI: NP_872363.1, UniProt: Q86UU0 |
Catalog # | MBS9610777 |
Price | $225, $280, $340 |
Order / More Info | Phospho-BCL9L (Ser21) Antibody from MYBIOSOURCE INC. |
Product Specific References | n/a |